HL Financial Services
PDLI

HL Financial Services’s PDL BioPharma, Inc. PDLI Stock Holding History

HL Financial Services’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-43,142
Closed -$418K – 723
2014
Q2 		$418K Buy
+43,142
New +$385K 0.01% 463
2013
Q4 		– Sell
-55,076
Closed -$439K – 663
2013
Q3 		$439K Buy
+55,076
New +$443K 0.02% 380

Other funds holding PDLI

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Advisors Asset Management
Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

HL Financial Services's PDLI Position: Q3 2014 in Review

HL Financial Services sold out of PDL BioPharma, Inc. (PDLI) in Q3 2014, closing a stake of 43,142 shares — an estimated $418K sold.

HL Financial Services first reported a position in PDLI in Q3 2013 and held it in 2 quarters. The position peaked at $439K in Q3 2013. 231 funds tracked by Wall St. Rank hold PDLI as of Q3 2014.

  • HL Financial Services reported no remaining PDL BioPharma, Inc. position as of Q3 2014 after selling out during the quarter.
  • HL Financial Services sold 43,142 PDL BioPharma, Inc. shares in Q3 2014, an estimated $418K.
  • HL Financial Services first reported a position in PDL BioPharma, Inc. in Q3 2013 and held it in 2 quarters.
  • HL Financial Services's PDL BioPharma, Inc. position peaked at $439K in Q3 2013.
  • 231 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2014.

Based on HL Financial Services's 13F filing for Q3 2014, filed 27 Oct 2014.